An Interview With Kfir Oved, CEO of Canopy Biotech, Which is Pursuing Novel Treatments in MG

Episode 186  ·  Aug 18, 2025, 06:00 PM
Headliner
Share
Subscribe

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Kfir Oved about the latest Israeli research on myasthenia gravis.

Share
Subscribe
Next
An Interview With Dr. Pradeep P.A. Mammen on Females With Duchenne Muscular Dystrophy
Top episodes
An Interview WIth Tracy Sharp, a Patient With Lambert-Eaton Myasthenic Syndrome
by Rare Care Podcast
An Interview With Omer Abdul Hamid, MD, of Nemours Children's Hospital in Orlando, Florida
by Rare Care Podcast
A Discussion on Medullary Thyroid Carcinoma With Dr. David Goldenberg
by Rare Care Podcast